Report #2889203

Received Mar 16, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 45 yrs
State: MI
Recovered: Unknown
Vaccinated: Mar 16, 2026
Onset: Mar 16, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	X027728	IM / RA

Symptoms (2)

No adverse eventUnderdose

Symptom narrative

Patient was given a pediatric HEP B dose. No adverse reactions reported.

Current illness

physical N/A

Medical history

Gastrointestinal Recurrent cold sores Endocrine Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) - Primary Mixed hyperlipidemia Prediabetes Lumbar degenerative disc disease Muscle spasm Chronic low back pain OSA (obstructive sleep apnea Depression, unspecified Mild episode of recurrent major depressive disorder ADHD (attention deficit hyperactivity disorder), combined type Bee sting allergy ED (erectile dysfunction) Elevated liver function tests Environmental and seasonal allergies Generalized anxiety disorder Mental health problem Vitamin D deficiency

Other medications

venlafaxine (EFFEXOR-XR) 75 mg XR capsule venlafaxine (EFFEXOR-XR) 150 mg XR capsule 150 mg valacyclovir (VALTREX) 1 g tablet 1 mg, 2 TIMES DAILY quetiapine (SEROQUEL) 300 mg tablet quetiapine (SEROQUEL) 200 mg tablet 200 mg, EVERY BEDTI

Allergies

bee venom

Lab data

n/a